Shares of KP Tissue Inc. (TSE:KPT - Get Free Report) reached a new 52-week high on Monday . The company traded as high as C$9.27 and last traded at C$9.27, with a volume of 6359 shares. The stock had previously closed at C$9.16.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on KPT shares. National Bankshares lifted their target price on KP Tissue from C$8.50 to C$9.50 and gave the stock a "sector perform" rating in a research report on Thursday, May 22nd. TD Securities lifted their target price on KP Tissue from C$8.00 to C$9.00 and gave the stock a "hold" rating in a research report on Thursday, May 22nd. Finally, Desjardins lifted their target price on KP Tissue from C$8.50 to C$9.50 and gave the stock a "hold" rating in a research report on Thursday, May 22nd.
View Our Latest Stock Report on KP Tissue
KP Tissue Stock Up 1.3%
The business has a fifty day simple moving average of C$8.63 and a two-hundred day simple moving average of C$8.23. The company has a market capitalization of C$92.75 million, a price-to-earnings ratio of 14.53, a P/E/G ratio of -0.88 and a beta of 0.37.
KP Tissue Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 15th will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 7.76%. The ex-dividend date is Monday, June 30th. KP Tissue's payout ratio is 112.73%.
About KP Tissue
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
See Also
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
